Kopran Limited (BOM:524280)

India · Delayed Price · Currency is INR

183.10

-0.25 (-0.14%)

At close: Jun 16, 2026

-6.89% (1Y)

Market Cap	8.84B -1.1%
Revenue (ttm)	6.81B +8.2%
Net Income	257.31M -33.3%
EPS	5.33 -33.2%
Shares Out	48.29M
PE Ratio	34.35
Forward PE	n/a
Dividend	3.00 (1.64%)
Ex-Dividend Date	Sep 4, 2025

Volume	2,734
Open	183.40
Previous Close	183.35
Day's Range	180.65 - 184.00
52-Week Range	107.00 - 218.90
Beta	0.84
Analysts	Strong Buy
Price Target	74.00 (-59.58%)
Earnings Date	May 19, 2026

About Kopran

Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti- helminthics, anti-acne, anti-infective, anti-thrombotic, s... [Read more]

Industry Pharmaceutical Preparations

Founded 1958

Employees 1,024

Stock Exchange Bombay Stock Exchange

Ticker Symbol 524280

Full Company Profile

Financial Performance

In fiscal year 2026, Kopran's revenue was 6.81 billion, an increase of 8.23% compared to the previous year's 6.30 billion. Earnings were 257.31 million, a decrease of -33.26%.

Financial Statements